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Abstract 32 
Purpose: To gain an exploratory insight into the relationship between training load (TL), 33 
salivary secretory immunoglobulin A (sIgA) and upper respiratory tract illness (URI) in elite 34 
paratriathletes. 35 
Methods: Seven paratriathletes were recruited. Athletes provided weekly saliva samples for the 36 
measurement of sIgA over 23 consecutive weeks (February - July) and a further 11 consecutive 37 
weeks (November – January). sIgA was compared to individuals’ weekly training duration, 38 
external TL and internal TL, utilising time spent in pre-determined heart rate zones. 39 
Correlations were assessed via regression analyses. URI was quantified via weekly self-report 40 
symptom questionnaire. 41 
Results: There was a significant negative relationship between athletes’ individual weekly 42 
training duration and sIgA secretion rate (p = 0.028) with changes in training duration 43 
accounting for 12.7% of the variance (quartiles: 0.2%, 19.2%). There was, however, no 44 
significant relationship between external or internal TL and sIgA parameters (p ≥ 0.104). There 45 
was no significant difference in sIgA when URI was present or not (101% vs 118% healthy 46 
median concentration; p ≥ 0.225); likewise, there was no difference in sIgA when URI occurred 47 
within two weeks of sampling or not (83% vs 125% healthy median concentration; p ≥ 0.120). 48 
Conclusions: Paratriathletes’ weekly training duration significantly affects sIgA secretion rate, 49 
yet we did not find a relationship between external or internal TL and sIgA parameters. Further, 50 
it was not possible to detect any link between sIgA and URI occurrence which throws into 51 
question the potential of using sIgA as a monitoring tool for early detection of illness.  52 
 53 
Key words: mucosal immune function, disability, triathlon, monitoring, TRIMP  54 
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Introduction 55 
Paratriathlon is a variant of triathlon modified for individuals with a physical impairment.1 It 56 
has been shown that paratriathletes produce large training loads (TLs) to maximise beneficial 57 
adaptations.1 However, there is a risk high TLs will increase the likelihood of illness,2 most 58 
commonly upper respiratory tract illness (URI)3 which can directly impair performance or limit 59 
training availability.2  60 
A key antibody in host defence is salivary secretory immunoglobulin A (sIgA). sIgA has 61 
been acknowledged as the first line of defence in mucosal immunity.4 Several authors have 62 
shown that, over prolonged periods, depressions in sIgA, proposed to be modulated by high 63 
TLs with insufficient recovery,5 increase the likelihood of URI.6,7 To date, this research has 64 
focused on able-bodied athletes. However, some have studied Paralympic populations, whom 65 
may be at heightened risk of URI due to their propensity for excessive overload, and therefore 66 
TLs, caused by movement inefficiencies.8 Whilst Leicht et al.9 presented a negative correlation 67 
between TL and sIgA in Paralympic athletes, there is currently little consensus regarding the 68 
effects of TL on mucosal immunity in this population.10 Furthermore, there has been a wide 69 
variety of methods of external (ETL) or internal (ITL) TL representation in the literature, which 70 
likely have differing degrees of association to mucosal immunity.  71 
Therefore, the aim of this present study was to gain an exploratory insight into the effects 72 
of TL, quantified using objective measures, on sIgA and resultant URI incidence in 73 
paratriathletes. 74 
Methods 75 
Participants 76 
Seven elite, mixed impairment, paratriathletes participated in this study (Table 1). All provided 77 
written informed consent and the procedures were approved by the University Ethical Advisory 78 
Committee. All had regularly competed at international level for 2 to 7 years, with six 79 
competing at the 2016 Paralympic Games and all reported being free from illness prior to the 80 
commencement of the study. Athletes’ typical weekly training volume was 11.2 ± 3.9 h. 81 
Study design 82 
Saliva samples were collected over 23 consecutive weeks (February – July) and a further 11 83 
consecutive weeks (November - January) whilst athletes undertook their normal training and 84 
competition regimes. Athletes visited the laboratory three times (February, July and November) 85 
for testing of parameters used in TL quantification.1 Due to the variable nature of athletes’ 86 
schedules it was not possible to collect samples from every athlete each week (11 to 31 samples 87 
per athlete). 88 
Saliva collection and analysis 89 
Samples were collected on the same weekday (06:00 – 08:00 h) every week, before training, 90 
10 minutes after last fluid intake, whilst fasted and before brushing their teeth. Athletes 91 
provided a timed, unstimulated saliva sample. Sample volume was estimated assuming a saliva 92 
density of 1.00 g·ml-1.11 Saliva flow rate was calculated from sample volume and collection 93 
time. Upon sample provision, athletes completed a questionnaire capturing illness symptoms 94 
(14 in total) for the preceding seven days. Athletes recorded the number of days they 95 
experienced each symptom and the severity of each symptom on a three-point scale. The 96 
number of days each symptom persisted was multiplied by the severity rating and summed to 97 
provide an overall quantitative symptom score; a score ≥ 12 indicated the presence of URI.11 98 
Athletes also reported if training availability was affected. IgA concentration was determined 99 
by ELISA.9 Individuals’ healthy median sIgA concentration was calculated as the median of 100 
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concentrations when URI was not present.7 Secretion rate (SR) was calculated from sIgA 101 
concentration and saliva flow rate.11 102 
Laboratory testing and training load quantification 103 
Athletes performed both a cycling/handcycling and running/racing-wheelchair incremental 104 
exercise test for the determination of heart rate (HR) associated with aerobic (AeLT) and 105 
anaerobic (AnLT) lactate thresholds.1  106 
Training was represented as total weekly duration for swim, cycle and run training. 107 
Resistance training was not included due to its small contribution to total weekly training. 108 
Further, ETL accounting for differences in the relative stress of triathlon modalities was 109 
calculated (Equation 1).12 ITL was calculated from an adaptation of the methods of Cejuela-110 
Anta and Esteve-Lanao12, incorporating the time spent in pre-determined zones (Equation 2), 111 
based on the HR associated with lactate thresholds.1 Due to the inability to record HR during 112 
swim training, this was represented solely by swim duration. Training duration, ETL and ITL 113 
were relativised to the highest individual weekly value recorded during the study period.  114 
Equation 1 115 
ETL = 0.75(swim duration) + 0.5(cycling duration) + (run duration) 116 
Equation 2 117 
ITL = [0.75(swim duration)] + [0.5(TIZ1C + 2[TIZ2C] + 3[TIZ3C])] + [(TIZ1R + 118 
2[TIZ2R] + 3[TIZ3R])] 119 
TIZnC – weekly time (min) spent in zone n during cycling. TIZnR – weekly time 120 
(min) spent in zone n during running. Zone 1 – below AeLT. Zone 2 – above AeLT, 121 
below AnLT. Zone 3 – above AnLT. 122 
Statistical analyses 123 
Statistical analyses were conducted using SPSS Statistics 23.0 (IBM, New York, USA); 124 
statistical significance was set at p < 0.05. Coefficients of variation were calculated for all 125 
saliva variables. Each salivary variable was matched to the athlete’s individual TL/training 126 
duration for the preceding seven days. A logarithmic transformation was applied to salivary 127 
variables to weight increases by a certain factor the same as decreases by the same factor.9 128 
Slopes of linear regression lines between salivary variables and TL/training duration were 129 
calculated for each athlete and compared, as a group, to a fixed zero with a Wilcoxon statistic. 130 
All salivary data were grouped, represented as relative deviation from individuals’ healthy 131 
median value and compared, via paired-samples t-test or Mann-Whitney U test, to elucidate to 132 
the likelihood URI occurrence within two weeks of sample provision. Similarly, salivary 133 
variables when URI were present were compared to samples when healthy (> 2 weeks to/from 134 
URI). 135 
Results 136 
132 saliva samples were collected. The between- and within-individual variability in sIgA 137 
concentration was 70% and 40%, respectively, whilst sIgA SR variability was 88% and 46%, 138 
respectively. Athletes’ mean sIgA concentration and SR were 162 ± 127 μg·ml-1 and 78 ± 76 139 
μg·min-1, respectively.  140 
There was a significant negative relationship between athletes’ total training duration 141 
and sIgA SR (p = 0.028; Figure 1). The amount of variance in sIgA SR explained by changes 142 
in training duration was 12.7% (quartiles 0.2%, 19.2%). There was no significant relationship 143 
between ETL (p ≥ 0.398) or ITL (p ≥ 0.104) and sIgA SR or concentration.  144 
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Six athletes reported at least one URI occurrence (range: 0 to 9 URI per athlete) with a 145 
total of 22 separate URI episodes. On average, athletes presented with URI every seven weeks 146 
and every 8 samples. During 50% of URI episodes, athletes had to reduce or suspend training. 147 
There was no significant difference in relative deviation from individual median sIgA 148 
concentration, SR or saliva flow rate between weeks with URI and when healthy (p ≥ 0.228) 149 
or between samples with URI within two weeks and samples without URI within two weeks 150 
(p ≥ 0.120) (Table 2).  151 
Discussion 152 
Training duration explained 12.7% of the variance in sIgA SR, albeit with large inter-individual 153 
variability. The variability is likely due to the individualised nature of which training affected 154 
mucosal immunity and we also acknowledge genetic, nutritional and psychological factors that 155 
may have an influence.9 There was, however, no significant relationship between ETL or ITL 156 
and sIgA. Relationships between TL and sIgA have been shown elsewhere in able-bodied 157 
sport,7 yet, Leicht et al.9 are the only researchers to note this interaction in a Paralympic 158 
population. This study, however, was conducted in an intermittent ball sport with solely spinal 159 
cord injured athletes, thus, was disparate from the multi-impairment endurance sport of 160 
paratriathlon. Further, the aforementioned study relied upon subjective measures of TL 161 
quantification rather than objective parameters such as HR. 162 
 Here, athletes averaged one URI episode every seven weeks, significantly greater than 163 
the four URI episodes annually previously reported.6 This may be due to Paralympic athletes’ 164 
vulnerability to illness as a consequence of movement inefficiencies increasing the likelihood 165 
of excessive overload.8 Nonetheless, in 50% of URI incidences, athletes stated that their 166 
training had been impaired. This highlights the desirability for identifying athletes at risk of 167 
illness prior to decrements in training or competitive performance.6 The present study, 168 
however, noted no relationship between salivary variables and URI incidence. A lack of 169 
relationship between sIgA and URI incidence has been reported elsewhere.2,9 Although sIgA 170 
plays a major role in mucosal immunity,4 there are many mechanisms responsible for host 171 
defence and insufficiencies in any, not merely sIgA, are likely to heighten the risk of illness.7  172 
Training duration was the only training measure significantly related to salivary 173 
parameters. This may signify a failing of the methods of Cejuela-Anta and Esteve-Lanao12 to 174 
adequately quantify ETL in its relation to URI incidence. As such, it is likely this method does 175 
not truly characterise the stress imposed on the mucosal immune system. Nonetheless, it was 176 
surprising that ITL did not relate to sIgA as this likely better represented the physical stress 177 
imposed by training than ETL.  178 
Practical Applications 179 
This exploratory study found depressions in sIgA SR during periods of high weekly training 180 
duration. Due to this, and Paralympic athletes’ propensity for illness, we recommend that 181 
measures are put in place to minimise the likelihood for missed or impaired training. This 182 
includes structuring and accurately monitoring TL to maximise recovery whilst lessening 183 
exposure to physical, environmental or psychological stressors.7 184 
 A limitation to the current study was the lack of mechanistic data to elucidate the 185 
relationship between training duration or TL and sIgA. Measurement of cortisol, a potential 186 
modulating factor in sIgA suppression,2,4 may have provided further insight into the causes of 187 
variation of sIgA.  188 
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Conclusions 189 
Paratriathletes’ weekly training duration is negatively correlated with sIgA SR, yet there is no 190 
significant relationship between ETL or ITL and sIgA parameters. Furthermore, it was not 191 
possible to detect any link between sIgA and URI occurrence.  192 
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Figure 1 Individual athletes’ salivary secretory immunoglobulin A (sIgA) secretion rate (SR) plotted against individual training duration with 
regression lines (lines are distorted by logarithmic scale). × Samples when URI was present. A-G are participant codes.  
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Table 1 Participant characteristics. Values mean ± standard deviation, where appropriate. 
Age (y) 30 ± 10 
Body mass (kg) 69.5 ± 6.5 
Cycling V̇O2peak (l·min-1) 4.06 ± 0.61 
Sex 6 male, 1 female 
Impairment 1 SCI (T6i), 1 unilateral transfemoral 
amputation, 1 hemiplegia cerebral palsy, 3 
unilateral transradial amputation, 1 lower leg 
impairment 
V̇O2peak – Peak rate of oxygen uptake. SCI – Spinal cord injury. T6i – Incomplete lesion at the 
6th thoracic vertebra. 
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Table 2 Relationship between URI state and URI occurrence within two weeks of sampling date on individual deviation of saliva data, median 
(quartiles). 
URI state sIgA conc. 
(% indiv. median) 
P 
sIgA SR 
(% indiv. median) 
P 
Saliva flow rate 
(% indiv. median) 
P 
URI 101 (94, 117) 
0.225 
113 (98, 128) 
0.494 
107 (87, 131) 
0.478 
Healthy 118 (95, 139) 98 (85, 127) 94 (77, 117) 
URI within two 
weeks? 
      
Yes 83 (54, 151) 
0.120 
76 (49, 142) 
0.255 
100 (84, 105) 
0.937 
No 125 (107, 147) 111 (96, 141) 95 (74, 113) 
URI – Upper respiratory tract illness. sIgA – Salivary secretory immunoglobulin A. SR – Secretion rate. 
 
